B. Craene
Molecular Biology · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 41 citations into it; #7,793 of 17,773 by trust here, #10,864 by citations
- Oncology — 25 citations into it; #529 of 1,698 by trust here, #1,139 by citations
Whom B. Craene trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Craene overall
- Arthur W. Lambert
- D. Pattabiraman
- R. Weinberg
- M. Nieto
- David M. Gonzalez
- J. Tsai
- S. J. Serrano-Gomez
- Jianrong Lu
Papers from B. Craene's perspective
Ordered by how strongly the researchers B. Craene trusts endorse each paper. Same corpus, a different order for every researcher.
- The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. (Genes & Development)
- Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. (Cell)
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 (Nature Cell Biology)
- Migrating cancer stem cells — an integrated concept of malignant tumour progression (Nature Reviews. Cancer)
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells (Nature Cell Biology)
- The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. (Molecules and Cells)
- Correlation of Snail expression with histological grade and lymph node status in breast carcinomas (Oncogene)
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression (Nature Cell Biology)
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? (Nature Reviews. Cancer)
Their papers
- Regulatory networks defining EMT during cancer initiation and progression (2013) — 2,417 citations